Singapore markets open in 4 hours 48 minutes

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7100+0.5100 (+12.14%)
At close: 04:00PM EDT
4.7100 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 171.57M
Enterprise value 124.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)25.66
Price/book (mrq)11.57
Enterprise value/revenue 35.64
Enterprise value/EBITDA -0.58

Trading information

Stock price history

Beta (5Y monthly) 1.58
52-week change 341.89%
S&P500 52-week change 326.16%
52-week high 39.0100
52-week low 32.8300
50-day moving average 36.5370
200-day moving average 35.0732

Share statistics

Avg vol (3-month) 3701.43k
Avg vol (10-day) 31.15M
Shares outstanding 540.85M
Implied shares outstanding 641.82M
Float 819.04M
% held by insiders 13.56%
% held by institutions 155.91%
Shares short (30 Apr 2024) 43.35M
Short ratio (30 Apr 2024) 43.87
Short % of float (30 Apr 2024) 412.87%
Short % of shares outstanding (30 Apr 2024) 412.23%
Shares short (prior month 28 Mar 2024) 41.99M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 305 Jul 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,377.14%

Management effectiveness

Return on assets (ttm)-46.99%
Return on equity (ttm)-260.60%

Income statement

Revenue (ttm)3.5M
Revenue per share (ttm)0.16
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -45.91M
Net income avi to common (ttm)-54.19M
Diluted EPS (ttm)-2.5300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)52.23M
Total cash per share (mrq)1.91
Total debt (mrq)5.4M
Total debt/equity (mrq)36.42%
Current ratio (mrq)4.15
Book value per share (mrq)0.56

Cash flow statement

Operating cash flow (ttm)-37.01M
Levered free cash flow (ttm)-18.89M